Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 501–600 of 1,062
Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?
Vona, R., Iessi, E., & Matarrese, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.622908 · Cited by 185
“HMGCoA is highly regulated at transcriptional, translational, and post-translational planes (Goldstein and Brown, 1990).”
BackgroundChinese green tea lowers cholesterol level through an increase in fecal lipid excretion
Yang, T. T. C., & Koo, M. W. L. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00607-4 · Cited by 160
Krauss, R. M., Mangravite, L. M., Smith, J. D., Medina, M. W., Wang, D., Guo, X., Rieder, M. J., Simon, J. A., Hulley, S. B., Waters, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.708388 · Cited by 159
Targeting the Mevalonate Pathway in Cancer
Juarez, D., & Fruman, D. A. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.11.008 · Cited by 160
Lee, S. J., Ha, M. J., Lee, J., Nguyen, P., Choi, Y. H., Pirnia, F., Kang, W.-K., Wang, X.-F., Kim, S.-J., & Trepel, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10618 · Cited by 160
Martirosyan, A., Clendening, J. W., Goard, C. A., & Penn, L. Z. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-103 · Cited by 160
“Statins inhibit the rate-limiting enzyme of the mevalonate (MVA) pathway, HMG-CoA reductase (HMGCR), and have been used for decades as safe and effective agents in the control of hypercholesterolemia[7,8] In addition to cholesterol, the MVA pathway gives rise to a number of crucial biochemical end-products, including…”
BackgroundGuevara-García, A., San Román, C., Arroyo, A., Cortés, M. E., de la Luz Gutiérrez-Nava, M., & León, P. (2005) · The Plant Cell · doi:10.1105/tpc.104.028860 · Cited by 161
“It has been shown that hydroxymethilglutaryl CoA reductase, a key enzyme for the MVA pathway, is regulated by a feedback mechanism in animals and plants by end products of the pathway (Goldstein and Brown, 1990; Wentzinger et al., 2002; Hemmerlin et al., 2003).”
BackgroundInhibition of the mevalonate pathway: benefits beyond cholesterol reduction?
Massy, Z. A., Keane, W. F., & Kasiske, B. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90217-2 · Cited by 160
Ericsson, J., Jackson, S. M., Lee, B. C., & Edwards, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.945 · Cited by 161
Mitochondria, cholesterol and cancer cell metabolism
Ribas, V., García‐Ruiz, C., & Fernández‐Checa, J. C. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0106-5 · Cited by 159
“The hydroxymethylglutaryl-CoA reductase (HMGCoAR) catalyzes the reduction of HMG CoA to mevalonate, the rate-limiting step in the synthesis of cholesterol [80].”
BackgroundMorand, O. H., Aebi, J. D., Dehmlow, H., Ji, Y. H., Gains, N., Lengsfeld, H., & Himber, J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37449-6 · Cited by 157
Catherine C. Y., C., Chen, J., Thomas, M. A., Cheng, D., Veronica A., D. P., Newton, R. S., Pape, M. E., & Chang, T.-Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29532 · Cited by 158
Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain
Lütjohann, D., Brzezinka, A., Barth, E., Abramowski, D., Staufenbiel, M., von Bergmann, K., Beyreuther, K., Multhaup, G., & Bayer, T. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200071-jlr200 · Cited by 158
“mammals is a very complex biochemical process that includes a great number of enzymatical reactions in earlystep (29) and late-step cholesterol synthesis (Fig.”
APOE and cholesterol homeostasis in Alzheimer's disease
Leduc, V., Jasmin-Bélanger, S., & Poirier, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.008 · Cited by 160
Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism
Zanotti, I., Dall'Asta, M., Mena, P., Mele, L., Bruni, R., Ray, S., & Del Rio, D. (2015) · Food & Function · doi:10.1039/c4fo00670d · Cited by 156
Infante, R. E., & Radhakrishnan, A. (2017) · eLife · doi:10.7554/elife.25466 · Cited by 163
Rodriguez-Concepcion, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1996 · Cited by 160
“, 1980) to inhibit HMG CoA reductase (HMGR) and to deplete cells of MVA, the precursor for the synthesis of FPP and GGPP (Goldstein and Brown, 1990).”
BackgroundInfluentialRobinson, G. W., Tsay, Y. H., Kienzle, B. K., Smith-Monroy, C. A., & Bishop, R. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2706 · Cited by 158
“For some genes of this family, such as HMG-CoA synthase, HMG-CoA reductase, and the low-density lipoprotein receptor, promoter analysis has shown that sequences termed SRE elements mediate sterol-regulated transcription (19), while for other genes, including squalene synthetase, this has not yet been determined.”
BackgroundImportance of a Novel Oxidative Mechanism for Elimination of Intracellular Cholesterol in Humans
Lund, E., Andersson, O., Zhang, J., Babiker, A., Ahlborg, G., Diczfalusy, U., Einarsson, K., Sjövall, J., & Björkhem, I. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.2.208 · Cited by 160
SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein.
Oliner, J. D., Andresen, J. M., Hansen, S. K., Zhou, S., & Tjian, R. (1996) · Genes & Development · doi:10.1101/gad.10.22.2903 · Cited by 157
Direct Vascular Effects of HMG-CoA Reductase Inhibitors
Laufs, U. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00044-x · Cited by 158
Baughman, J. M., Nilsson, R., Gohil, V. M., Arlow, D. H., Gauhar, Z., & Mootha, V. K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000590 · Cited by 157
“To validate the expression screening methodology, we first applied it to the well-studied and transcriptionally-regulated cholesterol biosynthesis pathway [29].”
MethodCentral role of peroxisomes in isoprenoid biosynthesis
Kovacs, W. J., Olivier, L. M., & Krisans, S. K. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00002-4 · Cited by 185
Streicher, R., Kotzka, J., Müller-Wieland, D., Siemeister, G., Munck, M., Avci, H., & Krone, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.7128 · Cited by 136
Metabolic Regulation of Gene Transcription in Mammals
Towle, H. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23235 · Cited by 160
Cellular cholesterol homeostasis and Alzheimer’s disease
Chang, T.-Y., Yamauchi, Y., Hasan, M. T., & Chang, C. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075630 · Cited by 155
“pend on prenylation for their biological functions (190).”
BackgroundStatins: a viable candidate for host-directed therapy against infectious diseases
Parihar, S. P., Guler, R., & Brombacher, F. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0094-3 · Cited by 165
Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Baldari, C. T. (2005) · The FASEB Journal · doi:10.1096/fj.04-2702fje · Cited by 154
“tatins are widely used hypocholesterolemic drugs that inhibit the activity of 3-hydroxy-3methylglutaryl-coenzyme A (HMG-CoA) reductase (1), a rate-limiting enzyme of the mevalonate pathway whose biosynthetic end product is cholesterol (2).”
BackgroundMethodInfluentialSidaway, J. E., Davidson, R. G., McTaggart, F., Orton, T. C., Scott, R. C., Smith, G. J., & Brunskill, N. J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000138236.82706.ee · Cited by 154
“Statins are inhibitors of the enzyme 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, the major rate-limiting step of the sterol pathway (1).”
BackgroundCholesterol metabolism in Huntington disease
Karasinska, J. M., & Hayden, M. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.132 · Cited by 154
Chauvin, B., Drouot, S., Barrail‐Tran, A., & Taburet, A. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0075-4 · Cited by 165
“Statins inhibit the synthesis of mevalonate, a rate-limiting step in cholesterol biosynthesis in the liver [36, 37], leading to a reduction in the plasma LDL-C level.”
BackgroundThe MEP Pathway: A New Target for the Development of Herbicides, Antibiotics and Antimalarial Drugs
Rodriguez-Concepcion, M. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384006 · Cited by 154
“es MVA and then isomerized to DMAPP in all organisms [1, 2, 4].”
BackgroundStatin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic Study
Agalliu, I., Salinas, C. A., Hansten, P. D., Ostrander, E. A., & Stanford, J. L. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn141 · Cited by 159
“3 INTRODUCTION Statin drugs are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase, the enzyme that controls the conversion of HMG-CoA to mevalonate, an essential precursor of cholesterol (1-3).”
Napoli, P. D., Taccardi, A. A., Grilli, A., Spina, R., Felaco, M., Barsotti, A., & Caterina, R. D. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00306-6 · Cited by 168
Wong, B., Lumma, W. C., Smith, A. M., Sisko, J. T., Wright, S. D., & Cai, T.-Q. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.959 · Cited by 156
“Some of these intermediates, such as farnesylpyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP), are substrates for the posttranslational isoprenylation of various proteins involved in cell signaling [ 6 , 7]. Results from several recent studies indicated that some of the direct effects of HMG-CoA reductase i…”
BackgroundSidebottom, P. J., Highcock, R. M., LANE, S. J., Procopiou, P. A., & Watson, N. S. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.648 · Cited by 154
Lawler, J. F., Yin, M., Diehl, A. M., Roberts, E., & Chatterjee, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5053 · Cited by 152
Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
Ginestier, C., Monville, F., Wicinski, J., Cabaud, O., Cervera, N., Josselin, E., Finetti, P., Guillé, A., Gaelle, L., Viens, P., et al. (2012) · Stem Cells · doi:10.1002/stem.1122 · Cited by 167
Towards efficient terpenoid biosynthesis: manipulating IPP and DMAPP supply
Wang, Q., Quan, S., & Xiao, H. (2019) · Bioresources and Bioprocessing · doi:10.1186/s40643-019-0242-z · Cited by 168
Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells
Yuan, L., Ma, X., Yang, Y., Qu, Y., Li, X., Zhu, X., Ma, W., Duan, J., Xue, J., Yang, H., et al. (2023) · Nature · doi:10.1038/s41586-023-06525-3 · Cited by 166
“Studies in the 1990s showed that the universal precursors of isoprenoids, isopen-tenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) 7 can weakly activate Vγ9Vδ2 T cells 8 , and these small molecules are known to accumulate intracellularly during tumorigenesis 9 .”
BackgroundQureshi, A., Qureshi, N., Hasler-Rapacz, J., Weber, F., Chaudhary, V., Crenshaw, T. D., GAPOR, A., Ong, A. S. H., Chong, Y. H., Peterson, D. M., et al. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.4.1042s · Cited by 152
Martin, P. D., Mitchell, P. D., & Schneck, D. W. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01688.x · Cited by 148
Kothe, H., Dalhoff, K., Rupp, J., Müller, A., Kreuzer, J., Maass, M., & Katus, H. A. (2000) · Circulation · doi:10.1161/01.cir.101.15.1760 · Cited by 151
Cell cycle regulation of metallothionein in human colonic cancer cells.
Nagel, W. W., & Vallee, B. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.579 · Cited by 152
Shimomura, I., Bashmakov, Y., Shimano, H., Horton, J. D., Goldstein, J. L., & Brown, M. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12354 · Cited by 132
Self-citationThe Role of Host Cholesterol During Flavivirus Infection
Osuna-Ramos, J. F., Reyes-Ruiz, J. M., & del Ángel, R. M. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00388 · Cited by 158
“, 2017) required for the synthesis of mevalonate, a precursor of the cholesterol, which is upregulated in response to cholesterol depletion (Goldstein and Brown, 1990).”
BackgroundCholesterol‐dependent balance between evoked and spontaneous synaptic vesicle recycling
Wasser, C. R., Ertunc, M., Liu, X., & Kavalali, E. T. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.123133 · Cited by 156
“This concentration of mevalonate during mevastatin treatment can maintain the level of isoprenoids, while not generating sufficient levels of cholesterol (Alberts et al. 1980; Brown & Goldstein, 1980; Goldstein & Brown, 1990; Simons et al. 1998).”
BackgroundmicroRNAs and cholesterol metabolism
Moore, K. J., Rayner, K. J., Suárez, Y., & Fernández-Hernando, C. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.008 · Cited by 151
“When cells accumulate excess sterols, the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase, a rate-limiting enzyme of the biosynthetic pathway, declines by more than 90% and the cell surface expression of LDLr decreases [6].”
BackgroundJuvenile Hormone Biosynthesis in Insects: What Is New, What Do We Know, and What Questions Remain?
Noriega, F. G. (2014) · International Scholarly Research Notices · doi:10.1155/2014/967361 · Cited by 154
“Although degradation plays a role, JH titer is primarily determined by the rate of biosynthesis in the corpora allata gland (CA).”
BackgroundBisphosphonates Are Potent Inhibitors of Trypanosoma cruzi Farnesyl Pyrophosphate Synthase
Montalvetti, A., Bailey, B. N., Martin, M., Severin, G. W., Oldfield, E., & Docampo, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103950200 · Cited by 151
Gardner, R. G., & Hampton, R. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31671 · Cited by 148
Tumor Necrosis Factor Receptor–Associated Periodic Syndrome
Toro, J. R., Aksentijevich, I. A., Hull, K. M., Dean, J., & Kastner, D. L. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.12.1487 · Cited by 149
“MVK codes for mevalonate kinase, an enzyme that phosphorylates mevalonic acid to 5-phosphomevalonic acid in the sterol biosynthesis pathway.(36,37) Biochemical analysis of skin fibroblasts from patients harboring MVK mutations have demonstrated 1% to 3% of the mevalonate kinase enzymatic activity found in control fibr…”
BackgroundSadowitz, B. D., Maier, K. G., & Gahtan, V. (2010) · Vascular and Endovascular Surgery · doi:10.1177/1538574410362922 · Cited by 166
“In a series of experiments with vascular endothelial cells, Laufs et al demonstrated that statin treatment upregulated eNOS expression and activity through stabilization of eNOS mRNA.14 Their study also demonstrated that statins can prevent the downregulation of eNOS expression and activity by oxLDL.14 Furthermore, st…”
InfluentialParadise, E. M., Kirby, J., Chan, R., & Keasling, J. D. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21766 · Cited by 148
“…have been observed to play a role in feedback regulation of some mevalonate pathway enzymes (Dimster-Denk and Rine, 1996; Gardner et al., 2001; Goldstein and Brown, 1990; Servouse and Karst, 1986), and artificial depletion of these sterols could increase flux through the mevalonate pathway to…”
BackgroundMethodJeong, A., Suazo, K. F., Wood, W. G., Distefano, M. D., & Li, L. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458070 · Cited by 146
Ravid, T., Doolman, R., Avner, R., Harats, D., & Roitelman, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004793200 · Cited by 149
Protein Farnesyltransferase and Protein Prenylation inPlasmodium falciparum
Chakrabarti, D., Da Silva, T., Barger, J., Paquette, S., Patel, H., Patterson, S., & Allen, C. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202860200 · Cited by 130
Ghosh‐Choudhury, N., Mandal, C. C., & Choudhury, G. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606706200 · Cited by 155
The biology of HMG-CoA reductase: the pros of contra-regulation
Hampton, R., Dimster-Denk, D., & Rine, J. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80168-x · Cited by 147
Statins Inhibit Proliferation and Induce Apoptosis in Barrett's Esophageal Adenocarcinoma Cells
Ogunwobi, O. O., & Beales, I. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01773.x · Cited by 147
“Although inhibition of HMG-CoA reductase by statins, leading to reduced cholesterol biosynthesis, is the most widely appreciated biological action, there are several other important roles of the cholesterol biosynthetic pathway distal to HMG-CoA reductase activity (34).”
BackgroundTopical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy
Atzmony, L., Lim, Y. H., Hamilton, C., Leventhal, J. S., Wagner, A. M., Paller, A. S., & Choate, K. A. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.08.043 · Cited by 150
“The mevalonate pathway is essential for cell growth and differentiation, gene expression, cytoskeleton assembly, and posttranslational modification of proteins involved in intracellular signaling (Fig 1).(12,13) Cholesterol, an end product of the mevalonate pathway, is a key component of the extracellular lipid matrix…”
BackgroundQureshi, A. A., Bradlow, B. A., Salser, W. A., & Brace, L. D. (1997) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(97)89667-2 · Cited by 147
Daumerie, C. M., Woollett, L. A., & Dietschy, J. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10797 · Cited by 148
Cinnamon (Cinnamomum zeylanicum) Oil as a Potential Alternative to Antibiotics in Poultry
Abd El-Hack, M. E., Alagawany, M., Abdel-Moneim, A.-M. E., Mohammed, N. G., Khafaga, A. F., Bin-Jumah, M., Othman, S. I., Allam, A. A., & Elnesr, S. S. (2020) · Antibiotics · doi:10.3390/antibiotics9050210 · Cited by 146
Alonso, D. F., Fariña, H. G., Skilton, G., Gabri, M. R., Lorenzo, M. S. D., & Gomez, D. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006058409974 · Cited by 146
Metabolic engineering of the astaxanthin-biosynthetic pathway of
VISSER, H., VANOOYEN, A., & VERDOES, J. (2003) · FEMS Yeast Research · doi:10.1016/s1567-1356(03)00158-2 · Cited by 146
“In many organisms, mevalonate synthesis, which is an early step in terpenoid biosynthesis, is a key point of regulation [28] of the corresponding pathway.”
BackgroundMechanisms of Giardia lamblia differentiation into cysts
Luján, H. D., Mowatt, M. R., & Nash, T. E. (1997) · Microbiology and Molecular Biology Reviews · doi:10.1128/.61.3.294-304.1997 · Cited by 173
Cholesterol inhibition, cancer, and chemotherapy
Buchwald, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90744-n · Cited by 146
Physiological and pathological implications of cholesterol
Cortés, V., Busso, D., Maiz, A., Arteaga, A., Nervi, F. O., & Rigotti, A. (2014) · Frontiers in bioscience · doi:10.2741/4216 · Cited by 157
“Importantly, isoprene intermediates in the mevalonate pathway generate a variety of other bioactive molecules, including ubiquinone and heme A, involved in the mitochondrial electron transport; dolichols, involved in glycoprotein synthesis; isopentyladenine, present in some transfer RNAs; and farnesyl and geranyl grou…”
BackgroundChakrabarti, R., & Engleman, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98884-8 · Cited by 145
Seybold, S. J., Bohlmann, J., & Raffa, K. F. (2000) · The Canadian Entomologist · doi:10.4039/ent132697-6 · Cited by 157
Cholesterol: A Novel Regulatory Role in Myelin Formation
Saher, G., Quintes, S., & Nave, K.-A. (2011) · The Neuroscientist · doi:10.1177/1073858410373835 · Cited by 144
Sagare, A. P., Deane, R., & Zlokovic, B. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.008 · Cited by 143
“Statins are cholesterol lowering drugs that reversibly inhibit the rate-limiting enzyme, hydroxymethylglutaryl-coenzyme A (HMGCoA) reductase, in cholesterol biosynthesis (Goldstein & Brown, 1990).”
BackgroundSadeghi, M. M., Collinge, M., Pardi, R., & Bender, J. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2712 · Cited by 146
The structure of the catalytic portion of human HMG-CoA reductase
Istvan, E. S. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00134-7 · Cited by 144
Identification and preliminary characterization of protein-cysteine farnesyltransferase.
Manne, V, Roberts, D., Tobin, A., O'Rourke, E., De Virgilio, M., Meyers, C., Ahmed, N., Kurz, B., Resh, M., & Kung, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7541 · Cited by 144
Autoinflammatory Diseases: Clinical and Genetic Advances
Farasat, S., Aksentijevich, I., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.392 · Cited by 143
Zhang, Y., Ma, K. L., Ruan, X. Z., & Liu, B. C. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14027 · Cited by 152
“In diabetic rats induced by a high fat/sucrose diet combined with low-dose intraperitoneal injection of streptozocin (STZ), Sun et al[79] observed lipid droplet accumulation in kidneys accompanied with increased the expression of HMGR and LDLR, whereas lipid-lowering agent, atorvastatin, alleviated the lipid disorder…”
BackgroundInfluentialCholesterol and phospholipid metabolism in macrophages
Tabas, I. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00146-3 · Cited by 158
Statins inhibit Rho kinase activity in patients with atherosclerosis
Nohria, A., Prsic, A., Liu, P.-Y., Okamoto, R., Creager, M. A., Selwyn, A., Liao, J. K., & Ganz, P. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.023 · Cited by 143
“Mevalonate is also essential for the formation of isoprenoid intermediates such as farnesylpyrophosphate and geranylgeranylpyrophosphate [1].”
BackgroundSerum Cholesterol and Cancer Risk: An Epidemiologic Persepective
Kritchevsky, S. B., & Kritchevsky, D. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.002135 · Cited by 146
Harshman, L. C., Wang, X., Nakabayashi, M., Xie, W., Valença, L. B., Werner, L. L., Yu, Y., Kantoff, A. M., Sweeney, C. J., Mucci, L. A., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0829 · Cited by 156
“Tx or unknown 230 (25) 173 (27) 57 (20)”
Colasante, C., Ellis, M., Ruppert, T., & Voncken, F. G. J. (2006) · PROTEOMICS · doi:10.1002/pmic.200500668 · Cited by 142
Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase
Istvan, E. S. (2002) · American Heart Journal · doi:10.1067/mhj.2002.130300 · Cited by 142
Disturbances in the normal regulation of SREBP-sensitive genes in PPARα-deficient mice
Patel, D. D., Knight, B. L., Wiggins, D., Humphreys, S. M., & Gibbons, G. F. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31655-2 · Cited by 142
Mensah, K., Mocanu, M. M., & Yellon, D. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.021 · Cited by 142
“eta-hydroxy-beta-methylglutaryl-CoA to mevalonate (1).”
Tijerino, A., Cardoza, R. E., Moraga, J., Malmierca, M. G., Vicente, F., Aleu, J., Collado, I. G., Gutiérrez, S., Monte, E., & Hermosa, R. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.11.012 · Cited by 152
“prenylated proteins, sterols, ubiquinones, dolichols and other secondary metabolites of pharmacological relevance (Goldstein and Brown, 1990; Chang and Keasling, 2006), as well as plant carotenoids, gibberellins, tocopherols and chlorophylls (Kirby and Keasling, 2009).”
BackgroundSchmitt, J., Kong, B., Stieger, B., Tschopp, O., Schultze, S. M., Rau, M., Weber, A., Müllhaupt, B., Guo, G. L., & Geier, A. (2015) · Liver International · doi:10.1111/liv.12456 · Cited by 135
“Hydroxymethylglutaryl-Coenzyme A reductase is the rate-limiting enzyme in cholesterol-homoeostasis and negatively controlled by intracellular cholesterol (31, 32).”
BackgroundYu, C., Kennedy, N. J., Chang, C. C. Y., & Rothblatt, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.24157 · Cited by 146
Yılmaz, A., Reiss, C., Tantawi, O., Weng, A., Stumpf, C., Raaz, D., Ludwig, J., Berger, T. G., Steinkasserer, A., Daniel, W. G., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.002 · Cited by 141
McDonough, V. M., Stukey, J., & Martin, C. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42644-0 · Cited by 140
Michikawa, M., & Yanagisawa, K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722278.x · Cited by 141
“…inhibiting DNA synthesis (Kaneko et al., 1978; Quesney-Huneeus et al., 1979, 1980, 1983; Habenicht et al., 1980; Brown and Goldstein, 1980; Perkins et al., 1982; Fairbanks et al., 1984; Siperstein, 1984; Maltese and Sheridan, 1985; Cuts et al., 1989; Goldstein and Brown, 1990; Pavlov et al., 1995).”
BackgroundCholesteryl esters in malignancy
Tosi, M. R., & Tugnoli, V. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.003 · Cited by 144
Clinical implications for statin pleiotropy
Liao, J. K. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000191913.16321.60 · Cited by 139
Bonovas, S., Filioussi, K., Flordellis, C. S., & Sitaras, N. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8936 · Cited by 141
Prevention of stroke and dementia with statins
Vaughan, C. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03270-8 · Cited by 148
Cholesterol starvation induces differentiation of the intestinal parasite Giardia lamblia.
Luján, H. D., Mowatt, M. R., Byrd, L. G., & Nash, T. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7628 · Cited by 139
Harwood, H., Chandler, C. E., Pellarin, L. D., Bangerter, F. W., Wilkins, R., Long, C., Cosgrove, P. G., Malinow, M. R., Marzetta, C. A., & Pettini, J. L. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40730-8 · Cited by 139
The Chemoprevention of Cancer by Mevalonate-Derived Constituents of Fruits and Vegetables
Elson, C. E., & Yu, S. G. (1994) · Journal of Nutrition · doi:10.1093/jn/124.5.607 · Cited by 139
Tam, P. P. L., & Tan, S.-S. (1992) · Development · doi:10.1242/dev.115.3.703 · Cited by 141
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.